Skip to main content
. 2022 May 30;8(2):00009-2022. doi: 10.1183/23120541.00009-2022

FIGURE 2.

FIGURE 2

Forest plots of selected biomarkers. a) The haemtological biomarker RDW: red cell distribution width; b) the metabolic biomarker LDL-c: low density lipid-cholesterol; c) the coagulation biomarker d-dimer; d) the inflammatory biomarker IL-6: interleukin-6; e) the cardiac biomarker NT-proBNP: N-terminal prohormone of brain natriuretic peptide; f) the renal biomarker UA: uric acid; CVD: cardiovascular disease. Risk of bias (QUADAS-2) – P: patient inclusion; I: index test (biomarker); R: reference standard (diagnosis); T: flow and timing. Publications in bold type represent biomarker levels of idiopathic pulmonary arterial hypertension (iPAH) and/or hereditary pulmonary arterial hypertension (hPAH) uniquely.

HHS Vulnerability Disclosure